Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | Xebra Brands Ltd (2): Xebra Brands closes $448,146 shares for debt deal | 2 | Stockwatch | ||
Do | Xebra Brands Ltd: Xebra Brands Announces Closing of Shares for Debt Transaction | 186 | ACCESS Newswire | NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES VANCOUVER, BC / ACCESS... ► Artikel lesen | |
XEBRA BRANDS Aktie jetzt für 0€ handeln | |||||
22.01. | Xebra Brands plans non-brokered private placement and concurrent debt settlement | 2 | Seeking Alpha | ||
22.01. | Xebra Brands Ltd (2): Xebra arranges private placement, debt settlement | 8 | Stockwatch | ||
22.01. | Xebra Brands Ltd: Xebra Brands Announces Non-Brokered Private Placement and Concurrent Debt Settlement | 307 | ACCESS Newswire | NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES VANCOUVER, BC / ACCESS... ► Artikel lesen | |
11.12.24 | Xebra Brands Ltd (2): Xebra Brands to extend 13.31 million warrants to June | 3 | Stockwatch | ||
11.12.24 | Xebra Brands Ltd: Xebra Brands Announces Warrant Extension | 250 | ACCESS Newswire | VANCOUVER, BC / ACCESSWIRE / December 11, 2024 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a cannabis company, is pleased to announce that, subject to the approval... ► Artikel lesen | |
07.11.24 | Xebra Brands Ltd (2): Xebra enters Mexican distribution deal for Elements | 11 | Stockwatch | ||
07.11.24 | Xebra Brands Ltd: Xebra Brands Executes First Distribution Agreement | 166 | ACCESS Newswire | ICAN Pharmacies to list ELEMENT Branded Products VANCOUVER, BC / ACCESSWIRE / November 7, 2024 / Xebra Brands ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a leading player in the Mexican... ► Artikel lesen | |
12.09.24 | Xebra Brands Ltd (2): Xebra extends expiry date of 13.31M warrants to Dec. 31 | 4 | Stockwatch | ||
12.09.24 | Xebra Brands Ltd: Xebra Brands Announces Warrant Extension | 313 | ACCESS Newswire | VANCOUVER, BC / ACCESSWIRE / September 12, 2024 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a cannabis company, is pleased to announce the extension of the expiry... ► Artikel lesen | |
19.07.24 | Xebra Brands Ltd: Xebra Brands Announces Closing of Shares for Debt Transaction | 350 | ACCESS Newswire | NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES VANCOUVER, BC / ACCESSWIRE... ► Artikel lesen | |
17.07.24 | Xebra Brands Ltd: Xebra Brands Engages Industry Leading CPG Executive to Lead Expansion into Mexico and US | 398 | ACCESS Newswire | VANCOUVER, BC / ACCESSWIRE / July 17, 2024 / Xebra Brands, a leader in the cannabis industry, is pleased to announce the engagement of MPC Co, a prominent consulting group in the cannabis space, led... ► Artikel lesen | |
26.06.24 | Xebra Brands Ltd: Xebra Brands Announces Strategic Update on Partnerships, Growth Opportunities, and Commercial Expansion | 352 | ACCESS Newswire | VANCOUVER, BC / ACCESSWIRE / June 26, 2024 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a developing cannabis company and the only company legally allowed to cultivate... ► Artikel lesen | |
10.06.24 | Xebra Brands Ltd: Xebra Brands Executes First Ever Purchase Order of CBD Products | 309 | ACCESS Newswire | VANCOUVER, BC / ACCESSWIRE / June 10, 2024 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), XEBRA, an evolving player in the cannabis industry, is proud to announce... ► Artikel lesen | |
04.06.24 | Xebra Brands Ltd: Xebra Brands Congratulates President Elect Claudia Sheinbaum on Historic Victory as Mexico's First Woman President | 380 | ACCESS Newswire | XEBRA Brands Inc Applauds President-Elect Claudia Sheinbaum's Stance on Cannabis Reform and Looks Forward to Collaboration for Industry Growth VANCOUVER, BC / ACCESSWIRE / June 4, 2024 / Xebra Brands... ► Artikel lesen | |
16.04.24 | Xebra Brands Ltd: Xebra Brands Receives Second CBD Product Approval by COFEPRIS | 305 | ACCESS Newswire | Xebra Expands Elements Brand of CBD products for Mexican Consumers VANCOUVER, BC / ACCESSWIRE / April 16, 2024 / Xebra Brands Ltd. (CSE:XBRA)(OTCQB:XBRAD)(FSE:9YC0) ("Xebra" or the "Company"), a leading... ► Artikel lesen | |
04.04.24 | Xebra Brands Ltd: Xebra Brands Submits Third Product Submission to COFEPRIS, Expanding Elements Brand CBD Lineup | 491 | ACCESS Newswire | VANCOUVER, BC / ACCESSWIRE / April 4, 2024 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a leading company in the CBD and cannabis industry, is proud to announce... ► Artikel lesen | |
26.03.24 | Xebra Brands Ltd Executes Manufacturing Agreement with Restorative Botanicals | 289 | ACCESS Newswire | VANCOUVER, BC / ACCESSWIRE / March 26, 2024 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a cannabis company, is excited to announce the signing of a manufacturing... ► Artikel lesen | |
21.03.24 | Xebra Brands Ltd: Xebra Brands Announces Closing of Shares for Debt Transaction and Grants Options | 439 | ACCESS Newswire | NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATESVANCOUVER, BC / ACCESSWIRE... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BAYER | 21,375 | -1,13 % | Bayer: Langzeitstudie stützt Eylea 8 mg bei nAMD | Bayer hat auf der Angiogenesis-Tagung in Miami neue Drei-Jahres-Daten zur Wirksamkeit von Eylea 8 mg bei neovaskulärer altersabhängiger Makuladegeneration (nAMD) vorgestellt. Die Ergebnisse der Verlängerungsstudie... ► Artikel lesen | |
AURORA CANNABIS | 6,030 | +0,17 % | Da ist Druck im Kessel: Canopy Growth taumelt. Aurora Cannabis mit Paukenschlag. Was macht Tilray? | © Foto: adobe.stock.comDie Quartalsberichtssaison hat den Cannabis-Sektor endgültig erreicht. Dass es einmal mehr keine einfache Berichtssaison werden würde, war zu erwarten. Immerhin gab es aber den... ► Artikel lesen | |
CANOPY GROWTH | 1,802 | +0,22 % | Canopy Growth Corporation Expands Deep Space Propulsion Beverage Lineup | ||
TILRAY BRANDS | 0,893 | +0,50 % | Tilray shifts large-scale production away from Revolver Brewing facility | ||
INNOCAN PHARMA | 0,117 | -1,69 % | Die liposomale CBD-Injektion von Innocan Pharma zeigt bei älterer Eselin mit Osteoarthritis bahnbrechende Schmerzlinderung | Dies ist die zweite erfolgreiche Behandlung bei einer Eselin, was das Potenzial der liposomalen CBD-Injektion von Innocan für die Anwendung
beim Menschen und in der Tiermedizin... ► Artikel lesen | |
CRONOS GROUP | 1,857 | -0,85 % | Cronos Group Inc. (CRON): A Bull Case Theory | ||
SYNBIOTIC | 4,170 | +3,22 % | SYNBIOTIC plant weitere Übernahmen in 2025 | Mitteilung der SYNBIOTIC SE: SYNBIOTIC mit vier neuen Beteiligungen in 2024: Weitere Übernahmen für 2025 in Sicht Die europäische Industriehanf- und Cannabis-Unternehmensgruppe SYNBIOTIC SE (ISIN DE000A3E5A59... ► Artikel lesen | |
NEKTAR THERAPEUTICS | 0,937 | -0,53 % | Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AD Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Moderate-to-Severe Atopic Dermatitis | SAN FRANCISCO, Jan. 10, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced the company has completed target enrollment in its REZOLVE-AD... ► Artikel lesen | |
ORAMED PHARMACEUTICALS | 2,349 | +2,49 % | Oramed Aktie: Schwierige Entscheidungen nötig | Der Biotechnologie-Konzern Oramed Pharmaceuticals durchläuft aktuell eine herausfordernde Phase an den Finanzmärkten. Mit einer Marktkapitalisierung von 84,9 Millionen Euro verzeichnet das Unternehmen... ► Artikel lesen | |
OPKO HEALTH | 1,606 | +2,45 % | OPKO Health, Inc.: ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program | Brings total awards from BARDA to $110 million for development of broad SARS-CoV-2 and Influenza multispecifics, with potential funding of up to $205 million if all options are executedDevelopment... ► Artikel lesen | |
JAGUAR HEALTH | 0,900 | +5,26 % | Jaguar Health, Inc.: Jaguar Health Presenting February 18 at Emerging Growth Conference to Provide Updates on Near-Term Catalysts | SAN FRANCISCO, CA / ACCESS Newswire / February 13, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO, will present virtually on Tuesday... ► Artikel lesen | |
SELLAS LIFE SCIENCES | 1,208 | -3,67 % | SELLAS Life Sciences Group, Inc.: SELLAS Life Sciences Announces Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of GPS in Acute Myeloid Leukemia | - REGAL Successfully Passes Event-Driven (60 Deaths) Interim Analysis for Efficacy, Futility, and Safety: The Independent Data Monitoring Committee (IDMC) Recommended Continuation of the Clinical... ► Artikel lesen | |
XORTX THERAPEUTICS | 0,868 | +2,36 % | XORTX fügt seiner Pipeline ein Programm der Spätphase zur Gichtbehandlung hinzu | - XORTX legt seinen Fokus auf ein Programm der Spätphase zur Behandlung der Gicht bei Allopurinol-Unverträglichkeit; Gespräche mit der FDA hinsichtlich eines NDA-Zulassungsantrags sind für
das... ► Artikel lesen | |
NUMINUS WELLNESS | 0,027 | 0,00 % | Numinus Wellness Inc: Numinus to wind down five subsidiaries | ||
TALPHERA | 0,589 | -4,69 % | Talphera, Inc.: Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study | Submission of a Prior Approval Supplement for a reduction in the number of patients in the NEPHRO CRRT study is expected within the coming week
The FDA agreed to... ► Artikel lesen |